Accolade, Inc. engages in the provision of personalized health and benefits solutions.
P/E
Net profit
P/B
Book value
P/FCF
FCF
Yield
Growth potential
Accolade, Inc. (Pennsylvania) news
28.04.2022
Accolade's GAAP loss for fiscal year 2022 was $123.124 million, up 2.4 times from $50.652 million in the previous year. Revenue increased 82% to $310.021 million from $170.358 million a year earlier.
Source: 
ir.accolade.com
ir.accolade.com
11.01.2022
Accolade's GAAP loss for 9 months of fiscal year 2022 was $88.568 million, up 92.8% from $45.926 million in the prior year. Revenue increased 94.6% to $216.265 million from $111.126 million a year earlier.
Source: ir.accolade.com
ir.accolade.com
08.10.2021
Accolade's GAAP loss for 6M 2022 fiscal year was $111.071 million, up 3.8 times from $29.331 million in the previous year. Revenue increased 82.7% to $132.815 million from $72.682 million a year earlier.
Source: ir.accolade.com
ir.accolade.com
09.07.2021
Accolade's GAAP loss for 3 months of fiscal year 2022 was $48.707 million, up 3.5 times from $13.96 million in the previous year. Revenue increased 65.8% to $59.527 million from $35.894 million a year earlier.
Source: ir.accolade.com
ir.accolade.com
General information
| Company name | Accolade, Inc. (Pennsylvania) |
|---|---|
| Sector | Health Care / Health Care Equipment & Services / Health Care Technology / Health Care Technology |
| Business address | 660 W. GERMANTOWN PIKE SUITE 500 PLYMOUTH MEETING PA 19462 347-574-3820 |
| Mailing address | 660 W. GERMANTOWN PIKE SUITE 500 PLYMOUTH MEETING PA 19462 |
| Website | www.accolade.com |
| Information disclosure | www.sec.gov |
English (US) 